AtriCure (ATRC) reported quarterly EPS of $0.18, beating the Zacks Consensus Estimate of $0.03 by $0.15. The result also swung from a year-ago loss of $(0.02) to a profitable quarter. The sizable EPS beat is likely to support near-term upside sentiment for the stock.
AtriCure (ATRC) reported quarterly EPS of $0.18, beating the Zacks Consensus Estimate of $0.03 by $0.15. The result also swung from a year-ago loss of $(0.02) to a profitable quarter. The sizable EPS beat is likely to support near-term upside sentiment for the stock.
AI-powered research, real-time alerts, and portfolio analytics for institutional investors.
Request DemoOverall Sentiment
strongly positive
Sentiment Score
0.55
Ticker Sentiment
